Progyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum
20 mars 2023 12h00 HE
|
Progyny
NEW YORK, March 20, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced...
Progyny Enhances Male Fertility Offering with the Expansion of its Reproductive Urologist Network
14 mars 2023 09h00 HE
|
Progyny
NEW YORK, March 14, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) a leading benefits management company specializing in fertility and family building benefits solutions, today announced the...
Detroit Pistons Become First Professional Sports Team in the United States to Partner with Progyny to Provide Comprehensive, Value-Based Family Building Care
01 mars 2023 09h00 HE
|
Progyny
NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) a leading benefits management company specializing in fertility and family building benefits solutions, today announced a...
Progyny, Inc. Announces Fourth Quarter 2022 Results
27 févr. 2023 16h03 HE
|
Progyny
Reports Full Year Revenue of $786.9 Million, Reflecting 57% GrowthReports Record Quarterly Revenue and Operating Cash Flow of $214.3 Million and $51.5 Million, RespectivelyIssues Financial Guidance...
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2022 Results Report
13 févr. 2023 16h44 HE
|
Progyny
NEW YORK, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, will report its...
Progyny to Discuss its Strong 2022 Financial Performance at Upcoming Investor Conference
09 janv. 2023 08h00 HE
|
Progyny
Anticipates Results to be at the High-End of its Previously Provided Financial GuidanceAnticipates Reporting Record Fourth Quarter Operating Cash Flow of Approximately $50 Million NEW YORK, Jan. 09,...
Progyny Raises 2022 Financial Guidance
28 nov. 2022 08h00 HE
|
Progyny
NEW YORK, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a leading benefits management company specializing in fertility and family building benefits...
Progyny, Inc. to Present at Credit Suisse 31st Annual Healthcare Conference
04 nov. 2022 12h00 HE
|
Progyny
NEW YORK, Nov. 04, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that...
Progyny, Inc. Announces Third Quarter 2022 Results
03 nov. 2022 16h01 HE
|
Progyny
Receives Record Number of New Client Commitments in Selling SeasonReports Record Quarterly Revenue of $205.4 Million, Reflecting 68% Growth Over the Prior Year PeriodRaises Full Year 2022 Guidance,...
Progyny, Inc. Announces Details for Its Third Quarter 2022 Results Report
18 oct. 2022 13h05 HE
|
Progyny
NEW YORK, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, will report its...